Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 6, 2000, Pages 528-536

  Joloba, M L ^a,b   Johnson, J L ^c,d   Namale, A ^a   Morrissey, A ^d   Assegghai, A E ^b   Mugerwa, R D ^a   Ellner, J J ^b,d   Eisenach, K D ^e  

^a MAKERERE UNIVERSITY   (Uganda)

^b JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Colony forming units; Culture; HIV; Mycobacterium tuberculosis; Radiometric

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; BACTERIAL COUNT; BACTERIUM CULTURE; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG CAVITATION; LUNG TUBERCULOSIS; LYMPHADENOPATHY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RADIOMETRY; SPUTUM ANALYSIS; SPUTUM SMEAR;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBIOTICS, ANTITUBERCULAR; COLONY COUNT, MICROBIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RIFAMPIN; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 0034126672     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Stott H, Patel A, Sutherland I, et al. The risk of tuberculosis infection in Uganda derived from the findings of national tuberculosis surveys. 1958 and 1970. Tubercle 1973; 54: 1-22.
2. Eriki P P, Okwera A, Aisu T, Morrissey A B, Ellner J J, Daniel T M. The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda. Am Rev Respir Dis 1991; 143: 185-187.
3. Adatu F. Report of the National TB Programme in Uganda. Kampala, Uganda: NTP; 1992.
4. Klein N C, Duncanson F P, Lenox T H III, Pitta A, Cohen S C, Wormser G P. Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest 1989; 95: 1190-1992.
5. Colebunders R L, Ryder R W, Nzilambi N, et al. HIV infection in-patients with tuberculosis in Kinshasha, Zaire. Am Rev Respir Dis 1989; 139: 1082-1085.
6. Kramer F, Modilevsky T, Wiliamy A R, Leedom J M, Barnes P F. Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med 1990; 89: 451-456.
7. Long R, Scalcini M, Manfreda J, et al. Impact of immunodeficiency virus type 1 on tuberculosis in rural Haiti. Am Rev Respir Dis 1991; 143: 69-73.
8. Long R, Scalcini M, Manfreda J, Jean-Baptiste M, Hershfield E. The impact of HIV on the usefulness of sputum smears for the diagnosis of tuberculosis. Am J Public Health 1991; 81: 1326-1328.
9. Elliot A M, Namasambo K, Allen B W, et al. Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tubercle 1993; 74: 191-194.
10. Alpert P L, Munsiff S S, Gourevitch M N, Greenberg B, Klein R S. A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis. 1997; 24: 661-668.
11. Johnson J L, Vjecha M J, Okwera A, et al. Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Int J Tuberc Lung Dis 1998: 2397-2404.
12. Brindle J R, Nunn P P, Githui W, Allen B W, Gathua S, Waiyaki P. Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis pulmonary tuberculosis. Am Rev Respir Dis 1993; 147: 958-961.
13. Pitchenick A E, Burr J, Suarez M, Fertel D, Gonzalez G, Moas G. Human T-cell lymphotropic virus III (HTLV-III) seropositivity and related disease among 71 consecutive patients in whom tuberculosis was diagnosed: a prospective study. Am Rev Respir Dis 1987; 135: 875-879.
14. Theuer C P, Hopewell P C, Elias D, Schecter G F, Rutherford G W, Chaisson R E. Human immunodeficiency virus infection in tuberculosis patients. J Infect Dis 1990; 162: 8-12.
15. Githui W, Nunn P, Juma E. Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results. Tubercle 1992; 73: 203-209.
16. Smith R L, Yew K, Berkowitz K A, Aranda C P. Factors affecting the yield of acid-fast sputum smears in patients with HIV and tuberculosis. Chest 1994; 106: 684-686.
17. Kent P T, Kubica G P. Public health mycobacteriology: a guide for the level III laboratory. US Department of Public Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta, GA, 1985.
18. Falk A, O'Connor J B, Pratt C, et al. Classification of pulmonary tuberculosis. In: Diagnostic Standards and Classification of Tuberculosis. 12th ed. New York: National Tuberculosis and Respiratory Disease Association, 1969; 6: 68-76.
19. Hobby G L, Holman A P, Iseman M D, Jones J M. Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob Agents Chemother 1973; 4: 94-104.
20. Siddiqi S. Radiometric (BACTEC) tests for slowly growing mycobacteria. In: Isenberg H D, ed. Clinical Microbiology Procedures Handbook. Washington, DC: American Society for Microbiology 1992: pp 7-25.
21. World Health Organization. Tuberculosis. WHO Fact Sheet No. 104. Geneva: WHO, 1998.
22. Lucas S B, Hounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a West African City. AIDS 1993; 7: 1569-1579.
23. Yajko D M, Wagner C, Tevere V J, Kocagoz T, Hadley W K, Chambers H F. Quantitative culture of Mycobacterium tuberculosis from clinical sputum specimens and dilution endpoint of its detection by Amplicor PCR assay. J Clin Microbiol 1995; 33: 1944-1947.
24. Kim T C, Blackman R S, Heatwole K M, Rochester D F. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Am Rev Respir Dis 1984; 129: 264-268.
25. Newman R, Doster B E, Murray F M, Woolpert S F. Rifampin in initial treatment of pulmonary tuberculosis. Am Rev Respir Dis 1974; 109: 216-232.
26. Mitchison D A. Understanding the chemotherapy of tuberculosis. Antimicrob Chemother 1992; 29: 477-493.
27. Kennedy N, Fox R, Kisyombe G M, et al. Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis. Am Rev Respir Dis 1993; 148: 1547-1551.
28. Chambers H F, Kocagoz T, Sipit T, Turner J, Hopewell P C. Activity of amoxicillin/clavulanate in patients with tuberculosis. Clin Infect Dis 1998; 26: 874-877.
29. Donald P R, Sirgel F A, Botha F J, et al. The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis. Am J Respir Crit Care Med 1997; 156: 895-900.
30. Yeager H Jr, Lacy J, Smith E R, Lemaistre C A. Quantitative studies of mycobacterial populations in sputum and saliva. Am Rev Respir Dis 1996; 95: 998-1004.
31. Telzak E E, Fazal B A, Pollard C E, Turrett G S, Justman J E, Blum S. Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clin Infect Dis 1997; 25: 666-670.
32. Murray J, Sonnenberg P, Shearer S C, Godfrey-Fausset P. Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. Am J Respir Crit Care Med 1999; 159: 733-740.
33. El-Sadr W M, Perlman D C, Matts J P, et al. Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG). Clin Infect Dis 1998; 26: 1148-1158.
34. Kassim S, Sassan-Morokro M, Ackah A, et al. Two-year followup of persons with HIV-1 and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa. AIDS 1995; 9: 1185-1191.
35. Chaisson R E, Clermont H C, Holt F, A, et al. Six-month supervised intermittent tuberculosis chemotherapy in Haitian patients with and without HIV infection. Am J Respir Crit Care Med 1996; 154: 1034-1038.
36. Ackah A N, Coulibaly D D, Digbeu H, et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abdijan, Côte d'Ivoire. Lancet 1995; 345: 607-610.
37. Blazes D L, Alwood K, Keruly J C, Moore-Rice K, Moore R D, Chaisson R E. Effectiveness of short-course treatment of HIV-related tuberculosis. J Invest Med 1995; 43 (Suppl 2): 369A.
38. Perriëns J H, St. Louis M E, Mukadi Y B, et al. Pulmonary tuberculosis in HIV-infected patients in Zaire: a controlled trial of treatment for either 6 or 12 months. N Engl J Med 1995; 332: 779-784.